Policy | February 02, 2024
Industry’s reaction to Union Budget 2024-25
Indian Pharma Post brings together the views of industry leaders on the Interim Union Budget 2024-25 announcement and its impact on the industry
Indian Pharma Post brings together the views of industry leaders on the Interim Union Budget 2024-25 announcement and its impact on the industry
Submission to be reviewed under FDA real-time oncology review and Project Orbis
The company intends to respond to the two minor observations within the stipulated time
The PAI was conducted for two drug product applications (ANDAs) filed from this facility
The certification underscores Venus Remedies Limited's adherence to stringent quality control measures
The clearance of this audit marks the successful registration of 8 APIs with CADIFA
MedTech Mitra is a platform that will help the young talents of the country by holding their hands and giving them final shape to their research, knowledge and logic
If approved, patritumab deruxtecan would be a first-in-class HER3 directed DXd antibody drug conjugate for these patients
Clariant Healthcare highlighted Vitipure Meglumine LEX and VitiPure Superior at the recently concluded CPhI India
Receives registration of Valganciclovir powder for oral solution in Germany
Subscribe To Our Newsletter & Stay Updated
